FDA Reverses Faulty Policy That Pushed Unreviewed Antibody Tests Into The Market
The Food and Drug Administration has passed a policy reversing a previous call that allowed unreviewed antibody tests flood the market. Read Story
The Food and Drug Administration has passed a policy reversing a previous call that allowed unreviewed antibody tests flood the market. Read Story